Latest Edwards Lifesciences News & Updates

See the latest news and media coverage for Edwards. We track all announcements, press releases, and industry mentions in real time, all in one place.

Edwards Lifesciences (Edwards)

Structural heart medical device manufacturer

edwards.com

Headquarters: Irvine, United States
Founded year: 1958
Company type: Public company
Number of employees: 10,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Edwards Lifesciences (Edwards)

In short: Edwards surpassed financial estimates in 2026, driven by strong heart valve sales, despite facing a $10 million antitrust penalty.

Company announcements

July 23 Edwards

Edwards reports Q2 2026 sales growth of 13.6%

Sales rose to $1.74B, driven by TAVR and TMTT; adjusted EPS of $0.78 beat expectations.

July 16 Edwards

Edwards announced Q2 2026 financial results

The earnings release includes forward-looking statements and non-GAAP reconciliations.

May 4 Edwards

Edwards Lifesciences announces CFO appointment

Theodora Mistras succeeds Scott Ullem effective end of May 2026. She joins from Viatris.

May 2 Edwards

Edwards announces 10-year COMMENCE trial results

Results show 97.9% freedom from structural valve deterioration for RESILIA tissue in aortic valves. Data presented at AATS meeting.

Media coverage

July 28 GuruFocus

EW Assumed by UBS -- Rating Upgraded to Buy with a Price Target

Edwards Lifesciences Upgraded to Buy by UBS On October 24, 2023, UBS has upgraded Edwards...

July 27 Yahoo Finance

Edwards Lifesciences (EW)'s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?

On July 23, Edwards Lifesciences Corporation (NYSE:EW) delivered second-quarter 2026 net sales of $1.74 billion, up 13.6% year over year (12.5% on a constant currency...

July 24 TradingView

Edwards Lifesciences Corporation Stock 12‑Month Price Target Raised to $101.57, Implies 21% Upside

Explore more price target data and ratings for Edwards Lifesciences Corporation on the Forecasts tab, and track all previous and future analyst recommendations for Edwards...

July 24 Investing.com

Leerink upgrades Edwards Lifesciences stock rating on TAVR momentum By Investing.com

Edwards Lifesciences trades at approximately 26.1 times consensus next-twelve-months price-to-earnings, near the top of its large-cap medical technology peer group. Leerink expects top-line and bottom-line...

Never miss news about Edwards

Track Edwards and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Edwards competitors & trending companies

Browse news for competitors to Edwards and other trending companies.